Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Asia Diagnostics Summit 2018

Takahiro Ochiya's Biography



Takahiro Ochiya, Chief, National Cancer Center Research Institute Japan

Dr. Takahiro Ochiya was a Chief of Division of Molecular and Cellular Medicine at the National Cancer Center Research Institute, Tokyo since 2011 and he is currently appointed as professor of Tokyo Medical University (since 2018). After he got Ph.D. in 1988 in Osaka University and then went to do a post-doc at La Jolla Cancer Research (Burnham Institute for Medical Research), CA, USA. Dr. Ochiya’s lab focuses the development of novel animal models, methods, and strategies to study cancer development and metastasis. Especially, current focuses are siRNA- and microRNA-based therapy against cancer stem cells. Dr. Ochiya is one of top scientist in Exosome research in cancer area and carries President of Japanese Society of Extracellular Vesicles (JSEV) since 2014.

Takahiro Ochiya Image

Exosome Diagnosis Presents a Novel Platform for Liquid Biopsy

Monday, 5 November 2018 at 09:00

Add to Calendar ▼2018-11-05 09:00:002018-11-05 10:00:00Europe/LondonExosome Diagnosis Presents a Novel Platform for Liquid BiopsyAsia Diagnostics Summit 2018 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com

Exosomes are 50-150 nm size in diameter extracellular vesicles (EVs) secreted by multiple living cells into the extracellular space. They contain tissue or cell-specific bioactive materials, including DNAs, mRNAs, ncRNAs, proteins, lipids, metabolites, etc. with their specific surface markers, such as, CD9, CD63, CD81, Alix, etc. Exosomes have been considered as information carriers in cell communication between cancer cells and non-cancer cells, which affect gene expressions and cellular signalling pathways of recipient cells by delivering their contents. Exosomes are promising tools for improving cancer care, but conversely may also contribute to tumor progression. Here, we highlight recently discovered roles of exosomes in modulating cancer microenvironment. We also discuss how exosomes could be exploited as biomarkers for a novel platform of liquid biopsy and delivery vehicles in cancer therapy.


Add to Calendar ▼2018-11-05 00:00:002018-11-06 00:00:00Europe/LondonAsia Diagnostics Summit 2018Asia Diagnostics Summit 2018 in Taipei, TaiwanTaipei, TaiwanSELECTBIOenquiries@selectbiosciences.com